Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
An update from Lantheus ( (LNTH) ) is now available.
Jeff Humphrey, MD, will no longer serve as Chief Medical Officer at Lantheus Holdings, Inc., with his last day being January 3, 2025. His departure is amicable and not due to any disagreements, and interim leadership of research and development will be handled by CEO Brian Markison and President Paul Blanchfield while a search for his replacement is conducted.
More about Lantheus
YTD Price Performance: 47.02%
Average Trading Volume: 995,222
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $6.34B
Learn more about LNTH stock on TipRanks’ Stock Analysis page.
